Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02272400 · ClinicalTrials.gov registry record · NA
Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 310
- Enrollment target
NCT02272400 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 310 participants.
The verdict
NCT02272400, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 310 participants
- Enrollment target
Study Summary
Partial breast irradiation (PBI) is becoming a new paradigm for breast cancer radiation.\[1\] No type I or II evidence is currently available to demonstrate equivalence to standard whole breast radiotherapy, and a prospective randomized trial jointly sponsored by NSABP and RTOG (NSABP B-39 and RTOG 0413) is currently accruing patients, comparing whole breast radiotherapy to PBI, either by brachytherapy or external beam techniques (EB). Until the results of this or similar trials are available, PBI remains a research domain, and it should be offered to patients only in the context of a clinical experimental protocol.
Interventions
- OTHER IGRT for prone partial breast irradiation (PBI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 310 participants |
| Start Date | 2007-08-07 |
| Est. Completion | 2014-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02272400
The ClinicalTrials.gov registry entry for NCT02272400 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 310 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which IGRT for prone partial breast irradiation (PBI) is the first listed.
NCT02272400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02272400 about?
NCT02272400 is a clinical study titled "Image Guided Radiotherapy (IGRT) for Prone Partial Breast Irradiation". Partial breast irradiation (PBI) is becoming a new paradigm for breast cancer radiation.\[1\] No type I or II evidence is currently available to demonstrate equivalence to standard whole breast radiotherapy, and a prospective randomized trial jointly sponsored by NSABP and RTOG (NSABP B-39 and RTOG ...
What is the current status of trial NCT02272400?
This trial is currently completed. It is a NA study. The enrollment target is 310 participants. The study started on 2007-08-07. Estimated completion is 2014-10-29.
What interventions are being tested in trial NCT02272400?
The interventions under investigation include: IGRT for prone partial breast irradiation (PBI) (OTHER).
Who is sponsoring clinical trial NCT02272400?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.